Robert Stewart - Allergan Plc President

AGN -- USA Stock  

  Buyout Trend

  President
Mr. Robert A. Stewart is no longer Chief Operating Officer of Allergan Plc., Prior to his current appointment, Mr. Stewart served as President, Generics and Global Operations from March 2015 to May 2016 Chief Operating Officer from July 2014 to March 2015 and President, Global Operations, from August 2010 to July 2014. He joined the Company in November 2009 as Senior Vice President, Global Operations. Prior to joining Watson, Mr. Stewart held various positions with Abbott Laboratories, Inc. from 2001 until 2009 where he most recently served as Divisional Vice President, Global Supply Chain, Quality Assurance and prior to this position served as Divisional Vice President for U.S.Puerto Rico and Latin America Plant Operations. Prior to joining Abbott Laboratories, Inc., he worked for Knoll Pharmaceutical Company from 1995 to 2001 and Hoffman LaRoche Inc
Age: 49        
862 261 7000  http://www.allergan.com
Stewart received B.S. degrees in Business Management / Finance from Fairleigh Dickinson University.

Robert Stewart Latest Insider Activity

Management Efficiency

The company has Return on Asset of 0.64 % which means that on every $100 spent on asset it made $0.64 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (12.97) % meaning that it generated no profit with money invested by stockholders.
The company has 23.24 B in debt with debt to equity (D/E) ratio of 38.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Allergan Plc has Current Ratio of 1.01 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Kurt KnabEvolus Inc Common Stock
2018
Atheer KaddisDiplomat Pharmacy
2016
Ramiro CabralElanco Animal Health Incorporat
2019
Mark LevineFlexion Therapeutics
2017
Adrian HepnerEagle Pharmaceuticals
2016
John MageeFlexion Therapeutics
2016
Sean BuckleyFibrocell Science
2018
Joel SabanDiplomat Pharmacy
2017
Antonio PeraEndo International Plc
2016
Crystal MuilenburgEvolus Inc Common Stock
2019
Myriam TheeuwesDURECT Corporation
2017
Blaise ColemanEndo International Plc
2016
Paul UrickDiplomat Pharmacy
2016
Gary RiceDiplomat Pharmacy
N/A
Lauren SilvernailEvolus Inc Common Stock
2018
David KinardElanco Animal Health Incorporat
2019
Gary KadlecDiplomat Pharmacy
2016
Amy FoxEvolus Inc Common Stock
2018
Peter VirsikESSA Pharma
2016
David UrbanekElanco Animal Health Incorporat
2018
Terri PowersDiplomat Pharmacy
2018

Entity Summary

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland. Allergan Plc operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 16900 people.Allergan Plc (AGN) is traded on BATS Exchange in USA. It is located in Clonshaugh Business and Technology Park and employs 16,900 people. Allergan Plc is listed under Pharmaceutical Products category by Fama And French industry classification.

Allergan Plc Leadership Team

Matthew Walsh, Chief Financial Officer, Executive Vice President
Robert Bailey, Chief Legal Officer and Corporate Secretary
Robert Stewart, Executive VP and President of Generic and Global Operations
Ronald Taylor, Independent Director
Adriane Brown, Independent Director
William Meury, Executive Vice President, Chief Commercial Officer
Brenton Saunders, Chairman of the Board, President, Chief Executive Officer
Wayne Swanton, Executive Vice President - Global Operations
Robert Hugin, Independent Director
Nicholson, Chief R&D Officer
Christopher Bodine, Independent Director
Karen Ling, Chief Human Resource Officer, Executive Vice President
Michael Gallagher, Lead Independent Director
Paul Bisaro, Executive Chairman
Thomas Freyman, Independent Director
Catherine Klema, Lead Independent Director
James DArecca, Chief Accounting Officer
Christopher Coughlin, Lead Independent Director
Nesli Basgoz, Independent Director
Philippe Schaison, Executive Vice President and President Allergan Medical
Maria Hilado, CFO and Executive VP
Joseph Boccuzi, Independent Director
Patrick OSullivan, Independent Director
Fred Weiss, Independent Director
A Bailey, Executive Vice President, Chief Legal Officer and Corporate Secretary
Alex Kelly, Chief Communications Officer
CDavid Nicholson, Executive Vice President, Chief R&D Officer
Carol Davidson, Independent Director
Michael Greenberg, Independent Director
Ron Taylor, Independent Director
Jonathon Kellerman, Executive Vice President Chief Compliance Officer
Paul Navarre, Executive Vice President and President International Brands
James Bloem, Independent Director
Karina Calzadilla, IR Contact Officer
Peter McDonnell, Independent Director

Stock Performance Indicators

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Allergan Plc Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Allergan Plc and Flexion Therapeutics. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.
Search macroaxis.com